May 2, 2023
The U.S. Food and Drug Administration on Wednesday approved the first pill form of fecal microbiota -- similar to what's known as fecal transplant therapy -- to treat the bacterial infection
Clostridioides difficile, one of the most common and deadly infections found in health care settings.